The American Kidney Fund (AKF) applauds the introduction of the federal Living Donor Protection Act of 2021 (H.R.1255/S.377), which would provide living organ donors important job protections while also protecting them from discrimination by life, disability and long-term care insurance carriers. The federal legislation would provide a uniform baseline of
Like more than 20 million other Americans, one of ReMed Pain and Wellness Clinic’s patients had been suffering from peripheral neuropathy for years. His feet would burn with numbness day in and day out, and nothing made it better. He was unable to sleep well because of the pain, nor
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company’s management will present at the J.P. Morgan 39th Annual Healthcare Conference on Thursday, January 14, 2021, at 9:10 a.m. ET, and will be
